Cite
Amato CM, Hintzsche JD, Wells K, et al. Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy. Cancers (Basel). 2020;12(7)doi: 10.3390/cancers12071943.
Amato, C. M., Hintzsche, J. D., Wells, K., Applegate, A., Gorden, N. T., Vorwald, V. M., Tobin, R. P., Nassar, K., Shellman, Y. G., Kim, J., Medina, T. M., Rioth, M., Lewis, K. D., McCarter, M. D., Gonzalez, R., Tan, A. C., & Robinson, W. A. (2020). Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy. Cancers, 12(7), . https://doi.org/10.3390/cancers12071943
Amato, Carol M, et al. "Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy." Cancers vol. 12,7 (2020). doi: https://doi.org/10.3390/cancers12071943
Amato CM, Hintzsche JD, Wells K, Applegate A, Gorden NT, Vorwald VM, Tobin RP, Nassar K, Shellman YG, Kim J, Medina TM, Rioth M, Lewis KD, McCarter MD, Gonzalez R, Tan AC, Robinson WA. Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy. Cancers (Basel). 2020 Jul 17;12(7). doi: 10.3390/cancers12071943. PMID: 32708981; PMCID: PMC7409244.
Copy
Download .nbib